Dr Reddy’s Laboratories, the Hyderabad-based pharma MNC, which also retails products via Amazon and other E-commerce channels in America is reportedly planning to double its portfolio on the US-headquartered E-commerce marketplace major to 50-plus products in the near future.
The company, as an experiment, had begun selling its OTC Habitrol brand nicotine patches on Amazon almost five years ago in 2016. Dr Reddy’s Laboratories followed it by adding Doan’s to the portfolio and two years later, Amazon connected to the domestic drug manufacturer looking for players that could rollout Amazon-exclusive brands in the OTC segment.
“At the current growth rate, the Amazon direct-to consumer channel is now a key growth driver for the OTC business and the team plans to launch products on Amazon first and then to other channels. Additionally, they anticipate ramping up to double their online portfolio to 50-plus products in the foreseeable future,” news agency PTI quoted the company as saying.